Address: No. 35, Simiao Road, Daxing Biomedical Industrial Base, Zhongguancun Science Park, Daxing District, Beijing
Copyright: Beijing Minhai Biological Technology Co., Ltd. Beijing ICP 10007676 Powered by www.300.cn Beijing Beijing Public Security No. 110115000037 Internet Drug Information Service Qualification Certificate (Beijing) Non-operating 20150173
Administrative Office: 010-59613600
Supplier consultation: 010-59613585
Medical support: 010-59613669
Leaders of Zhongguancun Management Committee visited Minhai Biology
On the afternoon of April 26, 2019, Zhai Lixin, director of the Beijing Zhongguancun Management Committee, and other leaders, accompanied by He Rui, Member of the Standing Committee of the Daxing District Committee, Deputy Director of the Beijing Municipal Committee, and Tian Dexiang, Secretary of the Working Committee of the Biomedical Base of the Daxing District, visited Beijing Minhai Biological Technology Co., Ltd. (hereinafter referred to as Minhai Biological) visited and inspected. Relevant leaders such as Zheng Haifa, general manager of Minhai Biology, Liu Jiankai, executive deputy general manager, and Xiao Qiyou, deputy general manager, accompanied the inspection.
Mr. Zheng accompanied Director Zhai and other leaders to visit the company's new R & D and production building, and introduced to the leaders the products of the new R & D and production building are inactivated Sabin strain polio vaccine, 13-valent pneumococcal conjugate vaccine, freeze-dried human rabies vaccine The basic situation of the workshop layout and production capacity, and discussed and exchanged on the high-quality development model of the vaccine industry.
After the visit, Director Zhai spoke highly of the development of Minhai Biology, fully affirmed the position of Minhai Biology in the biological vaccine industry, and encouraged the enterprises to continue to grow bigger and stronger, to be the vanguard of the industry, and to the company ’s current face. Employee hukou and children's education and other issues on-site solutions. General Manager Zheng said that the achievements of Minhai Biology benefited from the strong support and protection given by the biomedical base over the years, and said that he will continue to innovate in his future work, enhance the core competitiveness of the enterprise, and make greater contributions to the development of the economic prosperity contribution. Finally, on behalf of the company and all employees, President Zheng expressed gratitude to Beijing Zhongguancun Management Committee for his long-term care and support.